ORION CORPORATION INVESTOR NEWS
Orion’s Virtual Capital Markets Day today at 13.00 EEST – presentation material now available
Orion will arrange a virtual Capital Markets Day 2021 for investors, analysts and media today 13:00–16:00 EEST. The presentation material is now available on Orion’s website at https://www.orion.fi/en/cmd-2021
At the event, Orion's management will provide an update on the company's strategy and targets, business and research & development projects. The presentations are divided into two main themes which are ‘Creating growth towards 2025 target and beyond’ and ‘Creating long-term value’.
Speakers and programme
Main theme | Speaker |
Orion’s strategy and introduction | |
Creating growth towards 2025 target and beyond | |
Creating long-term value | |
Outi Vaarala, SVP, Research & Development | |
Conclusions |
Participants of the Capital Markets Day are kindly asked to register for the event through this link. Participants will have the opportunity to ask questions from Orion’s management during the event.
Contact person:
Tel. +358 10 426 2721
Publisher:
Communications
Orionintie 1A, FI-02200 Espoo,
www.orion.fi
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2020 amounted to
© OMX, source